Endothelial cells are protected against phagocyte-transmitted Chlamydophila pneumoniae infections by laminar shear stress. Gueinzius: Shear stress protects from C. pneumoniae infection

Atherosclerosis

Volumn 198, Issue 2, 2008, Pages 256-263

  Gueinzius, Katja ^a   Magenau, Astrid ^a   Erath, Sonja ^a   Wittke, Vanessa ^a   Urbich, Carmen ^b   Ferrando May, Elisa ^a   Dimmeler, Stefanie ^b   Hermann, Corinna ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Atherosclerosis; C. pneumoniae; Endothelial cells; Phagocytes; Shear stress

Indexed keywords

ARTICLE; ATHEROSCLEROSIS; BACTERIAL INFECTION; CELL PROTECTION; CHLAMYDOPHILA PNEUMONIAE; CONFOCAL MICROSCOPY; DISEASE TRANSMISSION; ENDOTHELIUM CELL; HEP 2 CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; LAMINAR FLOW; NEUTROPHIL; PHAGOCYTE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SHEAR STRESS; UMBILICAL VEIN;

ATHEROSCLEROSIS; CELLS, CULTURED; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; ENDOTHELIUM, VASCULAR; HUMANS; NEUTROPHILS; SHEAR STRENGTH;

EID: 43949099283     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.10.014     Document Type: Article

References (36)

1. Cunningham K.S., and Gotlieb A.I. The role of shear stress in the pathogenesis of atherosclerosis. Lab Invest 85 (2005) 9-23
2. Ieven M.M., and Hoymans V.Y. Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence. J Clin Microbiol 43 (2005) 19-24
3. Hermann C., Graf K., Groh A., Straube E., and Hartung T. Comparison of eleven commercial tests for Chlamydia pneumoniae-specific immunoglobulin G in asymptomatic healthy individuals. J Clin Microbiol 40 (2002) 1603-1609
4. Peeling R.W., Wang S.P., Grayston J.T., et al. Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results. J Infect Dis 181 (2000) S426-S429
5. Kuppuswamy V.C., and Gupta S. Antibiotic therapy for coronary heart disease: the myth and the reality. Drugs Today (Barc) 41 (2005) 677-685
6. Higgins J.P. Chlamydia pneumoniae and coronary artery disease: the antibiotic trials. Mayo Clin Proc 78 (2003) 321-332
7. de Kruif M.D., van Gorp E.C., Keller T.T., Ossewaarde J.M., and ten Cate H. Chlamydia pneumoniae infections in mouse models: relevance for atherosclerosis research. Cardiovasc Res 65 (2005) 317-327
8. Campbell L.A., and Kuo C.C. Chlamydia pneumoniae-an infectious risk factor for atherosclerosis?. Nat Rev Microbiol 2 (2004) 23-32
9. Gieffers J., van Zandbergen G., Rupp J., et al. Phagocytes transmit Chlamydia pneumoniae from the lungs to the vasculature. Eur Respir J 23 (2004) 506-510
10. Moazed T.C., Kuo C.C., Grayston J.T., and Campbell L.A. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis 177 (1998) 1322-1325
11. Azenabor A.A., Job G., and Adedokun O.O. Chlamydia pneumoniae-infected macrophages exhibit enhanced plasma membrane fluidity and show increased adherence to endothelial cells. Mol Cell Biochem 269 (2005) 69-84
12. Rupp J., Koch M., van Zandbergen G., et al. Transmission of Chlamydia pneumoniae infection from blood monocytes to vascular cells in a novel transendothelial migration model. FEMS Microbiol Lett 242 (2005) 203-208
13. Gaydos C.A., Summersgill J.T., Sahney N.N., Ramirez J.A., and Quinn T.C. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun 64 (1996) 1614-1620
14. Wolf K., Fischer E., and Hackstadt T. Degradation of Chlamydia pneumoniae by peripheral blood monocytic cells. Infect Immun 73 (2005) 4560-4570
15. van Zandbergen G., Gieffers J., Kothe H., et al. Chlamydia pneumoniae multiply in neutrophil granulocytes and delay their spontaneous apoptosis. J Immunol 172 (2004) 1768-1776
16. Mueller M., Postius S., Thimm J.G., et al. Toll-like receptors 2 and 4 do not contribute to clearance of Chlamydophila pneumoniae in mice, but are necessary for the release of monokines. Immunobiology 209 (2004) 599-608
17. Dimmeler S., Fleming I., Fisslthaler B., et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399 (1999) 601-605
18. Kettritz R., Gaido M.L., Haller H., et al. Interleukin-8 delays spontaneous and tumor necrosis factor-alpha-mediated apoptosis of human neutrophils. Kidney Int 53 (1998) 84-91
19. Yong E.C., Chi E.Y., Chen W.J., and Kuo C.C. Degradation of Chlamydia trachomatis in human polymorphonuclear leukocytes: an ultrastructural study of peroxidase-positive phagolysosomes. Infect Immun 53 (1986) 427-431
20. Yong E.C., Klebanoff S.J., and Kuo C.C. Toxic effect of human polymorphonuclear leukocytes on Chlamydia trachomatis. Infect Immun 37 (1982) 422-426
21. Prochnau D., Rodel J., Hartmann M., Straube E., and Figulla H.R. Growth factor production in human endothelial cells after Chlamydia pneumoniae infection. Int J Med Microbiol 294 (2004) 53-57
22. Kim M.P., Gaydos C.A., Wood B.J., et al. Chlamydia pneumoniae enhances cytokine-stimulated human monocyte matrix metalloproteinases through a prostaglandin E2-dependent mechanism. Infect Immun 73 (2005) 632-634
23. Rupp J., Hellwig-Burgel T., Wobbe V., et al. Chlamydia pneumoniae infection promotes a proliferative phenotype in the vasculature through Egr-1 activation in vitro and in vivo. Proc Natl Acad Sci USA 102 (2005) 3447-3452
24. Shi Y., and Tokunaga O. Chlamydia pneumoniae (C. pneumoniae) infection upregulates atherosclerosis-related gene expression in human umbilical vein endothelial cells (HUVECs). Atherosclerosis 177 (2004) 245-253
25. Yang X., Coriolan D., Schultz K., Golenbock D.T., and Beasley D. Toll-like receptor 2 mediates persistent chemokine release by Chlamydia pneumoniae-infected vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 25 (2005) 2308-2314
26. Dittrich R., Dragonas C., Mueller A., et al. Endothelial Chlamydia pneumoniae infection promotes oxidation of LDL. Biochem Biophys Res Commun 319 (2004) 501-505
27. Nazzal D., Cantero A.V., Therville N., et al. Chlamydia pneumoniae alters mildly oxidized low-density lipoprotein-induced cell death in human endothelial cells, leading to necrosis rather than apoptosis. J Infect Dis 193 (2006) 136-145
28. Kalvegren H., Bylin H., Leanderson P., et al. Chlamydia pneumoniae induces nitric oxide synthase and lipoxygenase-dependent production of reactive oxygen species in platelets. Effects on oxidation of low density lipoproteins. Thromb Haemost 94 (2005) 327-335
29. Alakarppa H., Surcel H.M., Laitinen K., et al. Detection of Chlamydia pneumoniae by colorimetric in situ hybridization. Apmis 107 (1999) 451-454
30. Gaydos C.A. Growth in vascular cells and cytokine production by Chlamydia pneumoniae. J Infect Dis 181 Suppl. 3 (2000) S473-S478
31. Mosorin M., Surcel H.M., Laurila A., et al. Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery. Arterioscler Thromb Vasc Biol 20 (2000) 1061-1067
32. Johnston S.C., Zhang H., Messina L.M., Lawton M.T., and Dean D. Chlamydia pneumoniae burden in carotid arteries is associated with upregulation of plaque interleukin-6 and elevated C-reactive protein in serum. Arterioscler Thromb Vasc Biol 25 (2005) 2648-2653
33. Rodriguez N., Fend F., Jennen L., et al. Polymorphonuclear neutrophils improve replication of Chlamydia pneumoniae in vivo upon MyD88-dependent attraction. J Immunol 174 (2005) 4836-4844
34. Wasserman S.M., and Topper J.N. Adaptation of the endothelium to fluid flow: in vitro analyses of gene expression and in vivo implications. Vasc Med 9 (2004) 35-45
35. Dautry-Varsat A., Subtil A., and Hackstadt T. Recent insights into the mechanisms of Chlamydia entry. Cell Microbiol 7 (2005) 1714-1722
36. Balana M.E., Niedergang F., Subtil A., et al. ARF6 GTPase controls bacterial invasion by actin remodelling. J Cell Sci 118 (2005) 2201-2210